DiaMedica raises $30.1M via private placement of 8.6M shares at $3.50 to fund preeclampsia pipeline

DiaMedica Therapeutics Inc.

Private placement of 8,606,426 common shares at $3.50 per share, raising $30.1M gross proceeds.
Closing expected July 23, 2025; no placement agent engaged.
Proceeds to support DM199 IND submission and Phase 2b study for preeclampsia and fetal growth restriction.
Registration rights agreement requires filing resale registration statement within 10 business days of closing.
Transaction involves non-management related parties; exempt from Canadian MI 61-101 valuation/minority approval.

item 1.01item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.